catalyst public relations merger sub, inc.

2711 centerville road
suite 400
wilmington, delaware 19808

NYS Entity Status
INACTIVE - Merged Out (May 06, 2014)

NYS Filing Date
MAY 06, 2014

NYS DOS ID#
4572716

County

Jurisdiction
DELAWARE

Registered Agent
NONE

NYS Entity Type
UNAUTHORIZED BUSINESS CORPORATION

Name History
2014 - CATALYST PUBLIC RELATIONS MERGER SUB, INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Shareholders weigh British American, Reynolds tobacco merger
    By EMERY P. DALESIO, AP Business Writer - Wednesday Jul 19, 2017

    RALEIGH, N.C. (AP) — Shareholders of British American Tobacco and Reynolds American Inc. were scheduled to decide Wednesday whether to approve a merger that would create the world's largest publicly traded tobacco company.The takeover marks an end for what became R.J. Reynolds Tobacco, which stamped its home state of North Carolina as a center during a bygone era of smoking's popularity through its Winston and Salem brands.

    Source: SFGATE.com: Top News Stories
  • The Messy Family Battle for Starrett City
    By CHARLES V. BAGLI - Tuesday Oct 31, 2017

    The fight over the fate of the massive Brooklyn housing complex pits a real estate tycoon’s widow against her stepchildren, with $900 million at stake.

    Source: NYT > Home Page
  • Big City: Lord & Taylor, WeWork and the Death of Leisure
    By GINIA BELLAFANTE - Friday Oct 27, 2017

    The sale of the department store’s flagship Fifth Avenue building marks the end of shopping as fun, and the rise of work as a way of life.

    Source: NYT > Home Page
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Op-Ed Contributor: Why the AT&T-Time Warner Merger Makes Sense
    By MICHAEL J. SANTORELLI - Thursday Nov 16, 2017

    The proposal will not hurt competition or consumers. The Justice Department has no solid antitrust reasons to block it.

    Source: NYT > Home Page